Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 579 for sleep

Edit search filters
  1. A Study to Evaluate a Multiplex Precision Medicine System for Early Warning of Progression Toward Shock After Trauma

    Rochester, MN

  2. Treatment of RLS/WED Symptoms Through Sensory Counter-stimulation

    Rochester, MN

  3. Rivet PVS Therapy in Group 2C

    Rochester, MN

  4. Implementation of a Web Based Real Time Clinical Decision Support Tool.

    Rochester, MN

  5. Study to Assess the Safety and Effectiveness of Oral BTD-001 in Adults with Idiopathic Hypersomnia

    Scottsdale/Phoenix, AZ

  6. Phase 2 Safety And Efficacy Study Of Tulisokibart (MK-7240/PRA023) In Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

    Scottsdale/Phoenix, AZ

  7. Does Pulmonary Rehabilitation Improve Frailty?

    Rochester, MN

  8. A Study of the Safety and Effectiveness of Suvorexant (MK-4305) for the Treatment of Insomnia in People who have Alzheimer's Disease

    Rochester, MN

  9. Sorafenib for Hepatopulmonary Syndrome

    Rochester, MN, Scottsdale/Phoenix, AZ

  10. Cardiothoracic Resident and Fellow Operative Autonomy (Zwisch Me!)

    Rochester, MN

.

Mayo Clinic Footer